Content about Genzyme

January 20, 2011
Report: Genzyme CEO calls acquisition by Sanofi-Aventis a long process

Finalizing an acquisition of biotech company Genzyme by French drug maker Sanofi-Aventis “will take some time,” media reports quoted Genzyme’s chief executive as saying.

January 10, 2011
Sanofi, Genzyme get closer to deal

It appears that French drug maker Sanofi-Aventis’ efforts to acquire U.S. biotech company Genzyme are getting somewhere, according to company and media reports.

December 13, 2010
Genzyme (again) turns down Sanofi-Aventis

Biotech company Genzyme still is saying “no thanks” to French drug maker Sanofi-Aventis’ tender offer of $18.5 billion, or $69 per share, to acquire it, saying the offer “substantially undervalues” the company.

November 22, 2010
Impax sued for patent infringement over generic Welchol

Impax confirmed a patent challenge for its version of a branded cholesterol drug that recently was submitted to the FDA for approval ...

November 17, 2010
Genzyme sells diagnostics biz

Biotech company Genzyme Corp. is selling its diagnostics business to Sekisui Chemical Co. for $265...

October 7, 2010
Genzyme again rejects Sanofi buyout offer

The board of directors of Genzyme again has rejected a buyout offer by French drug...

October 7, 2010
New report indicates times are a-changin' for drug market

The drug industry is undergoing a major paradigm shift. Companies that traditionally have relied on...

October 3, 2010
Sanofi-Aventis pursues Genzyme in hostile takeover

French drug maker Sanofi-Aventis has launched a hostile takeover bid to take over Cambridge, Mass.-based...

September 12, 2010
LabCorp to purchase Genzyme's genetic testing business

Laboratory Corp. of America Holdings will purchase a clinical testing business from Genzyme, Genzyme said...

August 30, 2010
Genzyme rejects Sanofi's second proposal

After Sanofi-Aventis sent Genzyme a second proposal letter to acquire the drug maker on Monday,...

August 29, 2010
Sanofi-Aventis seeks to acquire Genzyme for $18.5 billion

Sanofi-Aventis is looking to acquire Genzyme with a nonbinding proposal valued at approximately $18.5 billion....

August 25, 2010
Sanofi unwilling to increase bid with Genzyme

Biotech drug maker Genzyme’s takeover by French drug maker Sanofi-Aventis may have run into trouble,...

August 19, 2010
BioMarin Pharmaceutical acquires ZyStor Therapeutics

BioMarin Pharmaceutical has acquired privately owned biotechnology company ZyStor Therapeutics for $22 million, BioMarin said....

August 5, 2010
Genzyme, Isis announce study results for mipomersen

Biotech company Genzyme and Isis Pharmaceuticals have finished late-stage clinical trials of a cholesterol-lowering drug,...

August 2, 2010
Sanofi-Aventis becomes Genzyme's suitor

French drug maker Sanofi-Aventis has made an offer for Genzyme, according to published reports....

July 12, 2010
Watson seeks FDA approval for generic Renvela, confirms patent challenge

Generic drug maker Watson Pharmaceuticals hopes to be the first to market a version of...

July 7, 2010
Genzyme, Hospira reportedly ink packaging deal

Generic drug maker Hospira will fill and package several drugs for Genzyme, according to published...

July 5, 2010
Impax challenges Renvela patent

Generic drug maker Impax Labs is challenging the patent on a drug used to treat...

June 14, 2010
Genzyme's Campath gets fast-track designation from FDA

The Food and Drug Administration has agreed to speed up the review of a Genzyme...

May 25, 2010
Watson confirms patent challenge for generic Renvela

Generic drug maker Watson Pharmaceuticals is challenging the patent on a drug for treating kidney...

May 24, 2010
FDA approves Pompe disease treatment

The Food and Drug Administration has approved a new treatment for a rare genetic disorder...

May 23, 2010
Genzyme to correct manufacturing quality violations at Mass. plant

Biotech company Genzyme will pay $175 million to the federal government as part of an...

May 6, 2010
Reports: Billionaire investor seeks to push out Genzyme CEO

Billionaire investor Carl Icahn is trying to kick Genzyme CEO Henri Termeer off the company’s...

March 23, 2010
FDA to have Genzyme plant inspected, reviewed

Genzyme Corp. will have to submit to inspections of one of its plants by the...

March 7, 2010
Genzyme, PTC: Mid-stage trial for DBMD treatment yields mixed results

A mid-stage clinical trial of a drug for muscular dystrophy got mixed results, developers Genzyme...

© 2013 Drug Store News. All Rights Reserved.